BMI1 and head and neck squamous cell carcinoma: It was shown that inhibiting BMI1 sensitized tumors to cisplatin and eliminated lymph node metastasis in vivo, in vitro and primary human HNSCC samples contained highly tumorigenic, invasive, and cisplatin-resistant BMI1+ CSCs [39,40].